4//SEC Filing
Gray Nancy Ryan 4
Accession 0000886163-23-000043
CIK 0000886163other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 6:55 PM ET
Size
7.3 KB
Accession
0000886163-23-000043
Insider Transaction Report
Form 4
Gray Nancy Ryan
Director
Transactions
- Award
Common Stock
2023-06-09+1,142→ 6,567 total - Award
Non-Qualified Stock Option (right to buy)
2023-06-09+5,461→ 5,461 totalExercise: $73.76Exp: 2033-06-09→ Common Stock (5,461 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 9, 2023. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
- [F2]Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 9, 2023. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeother
Related Parties
1- filerCIK 0001714949
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 6:55 PM ET
- Size
- 7.3 KB